These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32276912)

  • 21. Synthesis and biological evaluation of genistein-O-alkylamine derivatives as potential multifunctional anti-Alzheimer agents.
    Hong C; Guo HY; Chen S; Lv JW; Zhang X; Yang YC; Huang K; Zhang YJ; Tian ZY; Luo W; Chen YP
    Chem Biol Drug Des; 2019 Feb; 93(2):188-200. PubMed ID: 30299583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.
    Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB
    Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and evaluation of 7H-thiazolo-[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors.
    Liu S; Shang R; Shi L; Zhou R; He J; Wan DC
    Chem Biol Drug Des; 2014 Aug; 84(2):169-74. PubMed ID: 24890706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel acetylcholinesterase inhibitors: Indolopyrazoline derivatives and molecular docking studies.
    Chigurupati S; Selvaraj M; Mani V; Selvarajan KK; Mohammad JI; Kaveti B; Bera H; Palanimuthu VR; Teh LK; Salleh MZ
    Bioorg Chem; 2016 Aug; 67():9-17. PubMed ID: 27231830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin.
    Wang J; Wang ZM; Li XM; Li F; Wu JJ; Kong LY; Wang XB
    Bioorg Med Chem; 2016 Sep; 24(18):4324-4338. PubMed ID: 27460699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, in vitro and in vivo evaluation of novel pyrrolizine-based compounds with potential activity as cholinesterase inhibitors and anti-Alzheimer's agents.
    El-Sayed NA; Farag AE; Ezzat MAF; Akincioglu H; Gülçin İ; Abou-Seri SM
    Bioorg Chem; 2019 Dec; 93():103312. PubMed ID: 31586715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multifunctional therapeutic approach: Synthesis, biological evaluation, crystal structure and molecular docking of diversified 1H-pyrazolo[3,4-b]pyridine derivatives against Alzheimer's disease.
    Umar T; Shalini S; Raza MK; Gusain S; Kumar J; Seth P; Tiwari M; Hoda N
    Eur J Med Chem; 2019 Aug; 175():2-19. PubMed ID: 31055149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of novel quinazoline-triazole hybrid compounds with potential use in Alzheimer's disease.
    Le-Nhat-Thuy G; Nguyen Thi N; Pham-The H; Dang Thi TA; Nguyen Thi H; Nguyen Thi TH; Nguyen Hoang S; Nguyen TV
    Bioorg Med Chem Lett; 2020 Sep; 30(18):127404. PubMed ID: 32717612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multitarget Strategy to Address Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and Computational Studies of Coumarin-Based Derivatives.
    Montanari S; Bartolini M; Neviani P; Belluti F; Gobbi S; Pruccoli L; Tarozzi A; Falchi F; Andrisano V; Miszta P; Cavalli A; Filipek S; Bisi A; Rampa A
    ChemMedChem; 2016 Jun; 11(12):1296-308. PubMed ID: 26507467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
    Gurung AB; Aguan K; Mitra S; Bhattacharjee A
    J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1,3-di-4-piperidylpropane derivatives as potential acetyl cholinesterase antagonists: Molecular docking, synthesis, and biological evaluation.
    Ahmed A; Akhtar S; Mushtaq N; Haider S; Munawar R; Siddique HA; Akram A; Saify ZS; Arif M
    Pak J Pharm Sci; 2021 May; 34(3):855-860. PubMed ID: 34602406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rational design and biological evaluation of a new class of thiazolopyridyl tetrahydroacridines as cholinesterase and GSK-3 dual inhibitors for Alzheimer's disease.
    Jiang X; Zhou J; Wang Y; Chen L; Duan Y; Huang J; Liu C; Chen Y; Liu W; Sun H; Feng F; Qu W
    Eur J Med Chem; 2020 Dec; 207():112751. PubMed ID: 32950908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer's disease.
    Khalid S; Zahid MA; Ali H; Kim YS; Khan S
    BMC Neurosci; 2018 Nov; 19(1):74. PubMed ID: 30424732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, Synthesis, and Biological Evaluation of Dual-Target Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 9A (PDE9A) for the Treatment of Alzheimer's Disease.
    Hu J; Huang YD; Pan T; Zhang T; Su T; Li X; Luo HB; Huang L
    ACS Chem Neurosci; 2019 Jan; 10(1):537-551. PubMed ID: 30252439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico studies, synthesis and pharmacological evaluation to explore multi-targeted approach for imidazole analogues as potential cholinesterase inhibitors with neuroprotective role for Alzheimer's disease.
    Gurjar AS; Darekar MN; Yeong KY; Ooi L
    Bioorg Med Chem; 2018 May; 26(8):1511-1522. PubMed ID: 29429576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
    Li RS; Wang XB; Hu XJ; Kong LY
    Bioorg Med Chem Lett; 2013 May; 23(9):2636-41. PubMed ID: 23511019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents.
    Yang J; Zhang P; Hu Y; Liu T; Sun J; Wang X
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):651-656. PubMed ID: 30746966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linarin improves the dyskinesia recovery in Alzheimer's disease zebrafish by inhibiting the acetylcholinesterase activity.
    Pan H; Zhang J; Wang Y; Cui K; Cao Y; Wang L; Wu Y
    Life Sci; 2019 Apr; 222():112-116. PubMed ID: 30802512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
    Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and evaluation of chromone-2-carboxamido-alkylbenzylamines as multifunctional agents for the treatment of Alzheimer's disease.
    Liu Q; Qiang X; Li Y; Sang Z; Li Y; Tan Z; Deng Y
    Bioorg Med Chem; 2015 Mar; 23(5):911-23. PubMed ID: 25678013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.